ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
152 hedge funds and large institutions have $768M invested in iTeos Therapeutics in 2022 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 72 increasing their positions, 32 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
4% less funds holding
Funds holding: 159 → 152 (-7)
34% less capital invested
Capital invested by funds: $1.17B → $768M (-$398M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
152
Holding in Top 10
3
Calls
$5.65M
Puts
$1.48M
Top Buyers
| 1 | +$15.8M | |
| 2 | +$11.1M | |
| 3 | +$10.9M | |
| 4 |
BlackRock
New York
|
+$8.03M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$7.86M |
Top Sellers
| 1 | -$21.4M | |
| 2 | -$15.7M | |
| 3 | -$14.5M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$14.3M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$10M |